ABSTRACT
Safe disposal of hazardous waste is becoming generally more important as industrial production increases. The pyrolysis characteristics and gas evolution of mixtures of several wastes are discussed in this paper. Experiments are described for various heating rates, particle sizes and final temperatures using thermogravimetric analysis (TGA) and a Fourier transform infrared spectrometer. The results indicate that there are three stages in the pyrolysis process. The composition of evolved gas includes carbon monoxide, carbon dioxide, ammonia, methane, nitric oxide, hydrocyanic acid and a number of other light alkanes. Gas evolution temperatures and gas generation rates were significantly influenced by the factors identified.
Subject(s)
Hazardous Waste , Paint , Refuse Disposal/methods , Spectroscopy, Fourier Transform Infrared/methods , Thermogravimetry/methods , Alkanes/chemistry , Ammonia/chemistry , Carbon Dioxide/chemistry , Carbon Monoxide/chemistry , Equipment Design , Gases , Hydrogen Cyanide/chemistry , Methane/chemistry , Nitric Oxide/chemistry , Spectrophotometry/methods , TemperatureABSTRACT
BACKGROUND & OBJECTIVE: Recently, high-dose docetaxel has been proved to be an effective antineoplastic drug in the treatment of metastatic breast cancer.However,there was a few reports about moderate-dose docetaxel and Adriamycin in the treatment of metastatic breast cancer. This study was designed to observe the response rate and toxic reaction of Taxotere and Taxotere plus Adriamycin in the treatment of metastatic breast cancer. METHODS: From September 1996 to April 2000, 34 cases with metastatic breast cancer, which were treated in Department of Oncology, The Second Central Hospital in Tianjin, were included in the study. For group A (14 cases), Taxotere single agent was administered at a dose of 75 mg/m(2) iv 1 hour. For group B, Taxotere was administered at a dose of 60 mg/m(2) combined with Adriamycin 50 mg/m(2) i.v. 1 hour. The same schedule for both groups was repeated every 21 days, with three cycles for all patients. RESULTS: The recent response rates of group A and group B were 57.14% (8/14) and 75.0% (15/20), respectively. The 2-and 4-year survival rates were 35.7%, 14.3% for group A, and 40.0%, 15.0% for group B. The median overall survival durations of group A and group B were 22 months and 23 months. The median overall response durations of these two groups were 10 and 11 months, respectively. The main adverse reactions of these two groups were neutropenia, nausea, vomiting, stomatitis, diarrhea, alopecia, fatigue, myalgia, fluid retention, and skin flushing. Grade 3 and grade 4 neutropenia occurred in group A and group B were 57.1% (8/14) and 70.0% (14/20), respectively. CONCLUSION: Taxotere is effective in the treatment of metastatic breast cancer. The toxic reactions are tolerable.
